Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bong Kwan Soh

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pharmaceutical Research|August 17, 2023
The Impact of Post-Processing Temperature on PLGA Microparticle PropertiesAndrew Otte, Bong Kwan Soh, Kinam Park
International Journal of Pharmaceutics|January 27, 2018
Liquid crystalline drug delivery vehicles for oral and IV/subcutaneous administration of poorly soluble (and soluble) drugsAndrew Otte, Bong-Kwan Soh, Gwangheum Yoon, et al.
International Journal of Pharmaceutics|August 29, 2017
The in vivo transformation and pharmacokinetic properties of a liquid crystalline drug delivery systemAndrew Otte, Yahira M Báez-Santos, Ellina A Mun, et al.
International Journal of Pharmaceutics|November 20, 2016
Formulation and characterization of a liquid crystalline hexagonal mesophase region of phosphatidylcholine, sorbitan monooleate, and tocopherol acetate for sustained delivery of leuprolide acetateYahira M Báez-Santos, Andrew Otte, Ellina A Mun, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 10, 2019
Injectable, long-acting PLGA formulations: Analyzing PLGA and understanding microparticle formationKinam Park, Sarah Skidmore, Justin Hadar, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pharmaceutical Research|August 17, 2023
The Impact of Post-Processing Temperature on PLGA Microparticle PropertiesAndrew Otte, Bong Kwan Soh, Kinam Park
International Journal of Pharmaceutics|January 27, 2018
Liquid crystalline drug delivery vehicles for oral and IV/subcutaneous administration of poorly soluble (and soluble) drugsAndrew Otte, Bong-Kwan Soh, Gwangheum Yoon, et al.
International Journal of Pharmaceutics|August 29, 2017
The in vivo transformation and pharmacokinetic properties of a liquid crystalline drug delivery systemAndrew Otte, Yahira M Báez-Santos, Ellina A Mun, et al.
International Journal of Pharmaceutics|November 20, 2016
Formulation and characterization of a liquid crystalline hexagonal mesophase region of phosphatidylcholine, sorbitan monooleate, and tocopherol acetate for sustained delivery of leuprolide acetateYahira M Báez-Santos, Andrew Otte, Ellina A Mun, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 10, 2019
Injectable, long-acting PLGA formulations: Analyzing PLGA and understanding microparticle formationKinam Park, Sarah Skidmore, Justin Hadar, et al.
Pageof 1